These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Review of current and future approaches to the management of benign prostatic hyperplasia. Gingell JC Postgrad Med J; 1992 Sep; 68(803):702-6. PubMed ID: 1282714 [No Abstract] [Full Text] [Related]
28. Endocrine and adrenergic pharmacological intervention in diseases of the prostate. Rane A Br J Clin Pharmacol; 1998 Apr; 45(4):329-37. PubMed ID: 9578179 [No Abstract] [Full Text] [Related]
29. [Non surgical treatment of benign prostatic hypertrophy. Past, present and future]. Rossetti R J Urol (Paris); 1993; 99(6):367-8. PubMed ID: 7516394 [No Abstract] [Full Text] [Related]
30. What will replace TURP? Brawer MK; McConnell JD; Oesterling JE Contemp Urol; 1992 Feb; 4(2):30-40. PubMed ID: 10151029 [TBL] [Abstract][Full Text] [Related]
31. Pharmacotherapy for benign prostatic hyperplasia. Narayan P; Indudhara R West J Med; 1994 Nov; 161(5):495-506. PubMed ID: 7528957 [TBL] [Abstract][Full Text] [Related]
32. Benign Prostatic Obstruction Relief in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Enlargement Undergoing Endoscopic Surgical Procedures or Therapy with Alpha-Blockers: A Review of Urodynamic Studies. Fusco F; Creta M; Imperatore V; Longo N; Imbimbo C; Lepor H; Mirone V Adv Ther; 2017 Apr; 34(4):773-783. PubMed ID: 28255867 [TBL] [Abstract][Full Text] [Related]
33. [Non surgical treatment of benign prostatic hypertrophy]. Martini E; Vaggi L; Rucci A; Di Clemente L J Urol (Paris); 1993; 99(6):278-82. PubMed ID: 7516366 [No Abstract] [Full Text] [Related]
36. [A randomized long-term comparative study of clinical efficacy of alpha 1-blocker with or without antiandrogen therapy for benign prostatic hyperplasia: focusing on improvement of I-PSS]. Ohtani M; Kikuchi K; Tsuchiya A; Noguchi R; Akaza H; Kondo F; Koiso K Hinyokika Kiyo; 2000 Nov; 46(11):791-7. PubMed ID: 11193299 [TBL] [Abstract][Full Text] [Related]
37. [Approach to benign hypertrophy of the prostate in primary health care]. Bentué Ferrer C; Córdoba García R Aten Primaria; 1995 Apr; 15(7):461-4. PubMed ID: 7539299 [No Abstract] [Full Text] [Related]
39. Evaluation of male sexual function in patients with Lower Urinary Tract Symptoms (LUTS) associated with Benign Prostatic Hyperplasia (BPH) treated with a phytotherapeutic agent (Permixon), Tamsulosin or Finasteride. Zlotta AR; Teillac P; Raynaud JP; Schulman CC Eur Urol; 2005 Aug; 48(2):269-76. PubMed ID: 15939527 [TBL] [Abstract][Full Text] [Related]
40. Benign prostatic hyperplasia. The Saudi perspective in the year 2000. Mosli HA; Atwa MA; Mahassini SH Saudi Med J; 2000 Oct; 21(10):915-20. PubMed ID: 11369951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]